Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Organ Transplantation | 7 | 2021 | 2616 | 0.99 | Why? |
Foscarnet | 1 | 2018 | 13 | 0.74 | Why? |
Ganciclovir | 1 | 2018 | 97 | 0.69 | Why? |
Encephalitis, Viral | 1 | 2018 | 355 | 0.52 | Why? |
Staphylococcus aureus | 1 | 2019 | 844 | 0.48 | Why? |
Antimicrobial Stewardship | 3 | 2020 | 931 | 0.48 | Why? |
Cytomegalovirus Infections | 1 | 2018 | 667 | 0.44 | Why? |
Graft Rejection | 2 | 2021 | 1766 | 0.44 | Why? |
Staphylococcal Infections | 2 | 2019 | 1099 | 0.42 | Why? |
Bacteremia | 1 | 2019 | 1372 | 0.36 | Why? |
Transplant Recipients | 6 | 2021 | 4982 | 0.31 | Why? |
Glucocorticoids | 2 | 2021 | 4431 | 0.30 | Why? |
Antibodies, Monoclonal, Humanized | 4 | 2021 | 9335 | 0.29 | Why? |
Kidney Transplantation | 2 | 2021 | 5397 | 0.26 | Why? |
Immunosuppressive Agents | 2 | 2021 | 6331 | 0.25 | Why? |
Referral and Consultation | 1 | 2019 | 4816 | 0.25 | Why? |
Transplantation, Homologous | 3 | 2019 | 757 | 0.22 | Why? |
Gaucher Disease | 1 | 2021 | 63 | 0.22 | Why? |
Receptors, Interleukin-2 | 1 | 2021 | 115 | 0.21 | Why? |
Hematopoietic Stem Cell Transplantation | 3 | 2019 | 2426 | 0.21 | Why? |
Sarcoma, Kaposi | 1 | 2018 | 97 | 0.17 | Why? |
Rare Diseases | 1 | 2021 | 373 | 0.17 | Why? |
Graft vs Host Disease | 2 | 2019 | 501 | 0.17 | Why? |
Herpesviridae Infections | 1 | 2018 | 172 | 0.16 | Why? |
Antiviral Agents | 2 | 2020 | 41703 | 0.15 | Why? |
Doxorubicin | 1 | 2018 | 313 | 0.15 | Why? |
Vancomycin | 1 | 2019 | 328 | 0.15 | Why? |
Immunologic Factors | 2 | 2021 | 4206 | 0.14 | Why? |
Interleukin-10 | 1 | 2021 | 1409 | 0.13 | Why? |
Liver Transplantation | 2 | 2021 | 2864 | 0.13 | Why? |
Antiretroviral Therapy, Highly Active | 1 | 2019 | 952 | 0.13 | Why? |
Rituximab | 1 | 2020 | 1096 | 0.12 | Why? |
Immunocompromised Host | 2 | 2019 | 5150 | 0.11 | Why? |
Immune System | 1 | 2021 | 1479 | 0.11 | Why? |
Heart Transplantation | 1 | 2021 | 1293 | 0.10 | Why? |
Humans | 22 | 2021 | 930598 | 0.09 | Why? |
Treatment Outcome | 5 | 2021 | 51732 | 0.09 | Why? |
Drug Therapy, Combination | 2 | 2021 | 7268 | 0.09 | Why? |
Health Resources | 1 | 2020 | 2592 | 0.08 | Why? |
Middle Aged | 12 | 2021 | 270681 | 0.08 | Why? |
Electronic Health Records | 1 | 2020 | 3492 | 0.08 | Why? |
Liver Neoplasms | 1 | 2018 | 1666 | 0.08 | Why? |
Survival Rate | 1 | 2020 | 9206 | 0.07 | Why? |
Retrospective Studies | 7 | 2021 | 105322 | 0.07 | Why? |
Hospitalization | 6 | 2021 | 54280 | 0.07 | Why? |
Cohort Studies | 4 | 2021 | 36005 | 0.07 | Why? |
Young Adult | 6 | 2021 | 93724 | 0.07 | Why? |
Inpatients | 1 | 2020 | 5161 | 0.07 | Why? |
Comorbidity | 4 | 2021 | 34796 | 0.07 | Why? |
Databases, Factual | 1 | 2019 | 6248 | 0.07 | Why? |
Female | 11 | 2021 | 380317 | 0.07 | Why? |
Aged, 80 and over | 4 | 2021 | 88759 | 0.06 | Why? |
Aged | 7 | 2021 | 215776 | 0.06 | Why? |
Algorithms | 1 | 2020 | 7346 | 0.06 | Why? |
Interleukin-6 | 1 | 2021 | 7522 | 0.06 | Why? |
Drug Repositioning | 1 | 2020 | 5683 | 0.06 | Why? |
Postoperative Complications | 1 | 2020 | 5861 | 0.06 | Why? |
Case-Control Studies | 1 | 2021 | 17671 | 0.06 | Why? |
Male | 10 | 2021 | 367725 | 0.06 | Why? |
New England | 1 | 2020 | 143 | 0.05 | Why? |
Registries | 1 | 2020 | 12327 | 0.05 | Why? |
Time Factors | 2 | 2020 | 31397 | 0.05 | Why? |
Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
Adult | 7 | 2021 | 244371 | 0.05 | Why? |
Virus Replication | 1 | 2020 | 14331 | 0.05 | Why? |
Heart Failure | 1 | 2020 | 6638 | 0.05 | Why? |
Connecticut | 1 | 2020 | 547 | 0.05 | Why? |
Cytokines | 1 | 2021 | 15010 | 0.05 | Why? |
Lymphoma, Follicular | 1 | 2019 | 109 | 0.04 | Why? |
Herpesvirus 8, Human | 1 | 2018 | 97 | 0.04 | Why? |
Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
Betacoronavirus | 3 | 2020 | 204454 | 0.04 | Why? |
Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
Anti-Bacterial Agents | 1 | 2019 | 10083 | 0.04 | Why? |
Febrile Neutropenia | 1 | 2019 | 179 | 0.04 | Why? |
Severity of Illness Index | 2 | 2021 | 48226 | 0.04 | Why? |
Bone Marrow | 1 | 2019 | 492 | 0.04 | Why? |
Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
Medication Therapy Management | 1 | 2019 | 312 | 0.04 | Why? |
Respiration, Artificial | 1 | 2020 | 22116 | 0.04 | Why? |
Allografts | 1 | 2018 | 761 | 0.04 | Why? |
Pandemics | 6 | 2021 | 389249 | 0.03 | Why? |
CD4 Lymphocyte Count | 1 | 2019 | 1517 | 0.03 | Why? |
Polyethylene Glycols | 1 | 2018 | 574 | 0.03 | Why? |
Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
HIV Infections | 1 | 2019 | 11620 | 0.03 | Why? |
Nose | 1 | 2019 | 1093 | 0.03 | Why? |
Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 711 | 0.03 | Why? |
Mass Vaccination | 1 | 2021 | 1101 | 0.03 | Why? |
Feasibility Studies | 1 | 2021 | 3467 | 0.03 | Why? |
Health Surveys | 1 | 2020 | 2841 | 0.02 | Why? |
Delivery of Health Care, Integrated | 1 | 2020 | 1549 | 0.02 | Why? |
Tissue Donors | 1 | 2018 | 1679 | 0.02 | Why? |
Software | 1 | 2020 | 2501 | 0.02 | Why? |
United States | 2 | 2021 | 46150 | 0.02 | Why? |
Liver | 1 | 2018 | 4007 | 0.02 | Why? |
Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.01 | Why? |
Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
Biomarkers | 1 | 2021 | 23361 | 0.01 | Why? |
RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
Lung | 1 | 2021 | 31049 | 0.01 | Why? |
Child | 1 | 2021 | 70012 | 0.01 | Why? |
Antibodies, Viral | 1 | 2020 | 51949 | 0.01 | Why? |
Malinis's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(104)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(171)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_